Conclusions. This study demonstrates that alkaline therapy Bone histology and bone mineral density after correction of corrects abnormal bone cell function and elevates bone mineral acidosis in distal renal tubular acidosis.
Distal renal tubular acidosis (dRTA) is a condition and bone histology before and after correction of acidosis among associated with impaired renal acid excretion, resulting patients with distal renal tubular acidosis (dRTA) in accumulation of acid in the body. The disease is associMethods. Correction of metabolic acidosis by potassium ciated with growth retardation [1] , skeletal pain, abnormal trate was done in non-azotemic dRTA patients, 6 females and bone metabolism, and pathologic fractures [2, 3] . Our 4 males, who had never received long-term alkaline therapy previous study on bone mineral metabolism in patients before enrolling into this study. Blood chemistries, serum intact with dRTA demonstrated significant suppression in both parathyroid hormone, and 24-hour urine collection for the determination of urinary calcium, phosphate, sodium, potassium, bone formation and bone resorption in association with bone mineral density determination, and transiliac bone biopsy mild elevation in osteoid volume [3] . Most dRTA patients were done in all patients at baseline and after one year of also had a marked reduction in bone mineral density of potassium citrate therapy. spine and hip [3] . A putative causal role of metabolic
Results. Significant elevations in serum bicarbonate (16.5 Ϯ acidosis in the development of skeletal growth retardation 3 .0 vs. 24.6 Ϯ 2.8 mEq/L, P Ͻ 0.05) and urinary potassium is supported by the fact that alkaline therapy normalized excretion (35.2 Ϯ 7.9 vs. 55.4 Ϯ3.5 mEq/L, P Ͻ 0.05) were observed after potassium citrate therapy. No significant alterbone growth in children with dRTA [1] . In vitro and ations in other serum and urine electrolytes were found after animal studies suggest that the abnormal bone metabothe therapy. Serum intact parathyroid hormone level was also lism in chronic metabolic acidosis results mainly from significantly elevated after one year of treatment (12. 8 Ϯ 7.3 both acidosis-induced physicochemical mineral dissoluvs. 26.2 Ϯ 8.7 pg/mL, P Ͻ 0.05). Bone formation rate was tion and later through alterations in bone cell function significantly suppressed at baseline and was normalized by the [4] [5] [6] [7] [8] . Limited human studies on the effects of alkaline treatment (0.02 Ϯ 0.02 vs. 0.06 Ϯ 0.03 m 3 /m 2 /day, P Ͻ 0.05).
therapy in the correction of the abnormal bone histology
There were non-significant elevations in trabecular bone volume, osteoblastic and osteoclastic numbers. Bone mineral denand bone mineral density are available. Most studies sities in dRTA patients were also significantly decreased below were case reports and provided no information on cellnormal values in most studied areas at baseline and were sigmediated-response to the alkaline-induced correction of nificantly elevated at the trochanter of femur (0.677 Ϯ 0.136 metabolic acidosis [9, 10] . The aim of this subsequent vs. 0.748 Ϯ 0.144 g/c m 2 , P Ͻ 0.05) and total femur (0.898 Ϯ study, therefore, was to examine the alteration in bone
This study was performed in idiopathic dRTA patients who were residents of Khon Kaen province, Thailand, where a very high incidence of dRTA has been reported fashion, using either 15 mEq or one package increment, until the desired serum bicarbonate level was reached. [11] . All subjects were a subgroup of the dRTA patients reported in our previous study on bone mineral density For patients who had an adequate response to the initial dosage of potassium citrate, there was no reduction in and histology [3] , who remained in the province throughout the study. However, only ten patients, four males the dosage below 60 mEq in order to ensure an adequate supply of potassium citrate throughout the study. The and six females, agreed to participate in our current study and completed the study protocol. The patient charactercompliance was checked by package count and determination of serum electrolytes. Follow-up was done at twoistics and presentations of this subgroup, summarized in Table 1 , were not different from the entire study populamonth intervals. No medication that might affect calcium and bone metabolism, for example diuretics, vitamin D, tion reported previously. All patients had received only short-term treatment for their symptoms before enrollestrogen, bisphosphonate, and calcium supplement, was allowed throughout the study. After one year of alkaline ment into this study. Patient characteristics, clinical presentations, and approximated duration of the disease for therapy, all the investigations done at baseline were repeated. The second transiliac crest bone biopsy was done individual dRTA patient are presented in Table 1 . The total energy intake in this group of dRTA patients was in the opposite side to the first biopsy. The study was done while the patients were on their own choice of diet 1852.8 Ϯ 392.5 kcal/day, carbohydrate 380.52 Ϯ 85.9 g/day (82.1 Ϯ 18.6% of total calories), protein 55.2 Ϯ 13.4 g/day and the urine collections were done in an outpatient setting. There was no intention to modify their normal life (11.9 Ϯ 2.8% of total calories), and fat 14.1 Ϯ 8.4 g/day (6.1 Ϯ 3.6% of total calories). The calcium intake activity and diet throughout the study. was 9.45 Ϯ 4 mmol/day.
Biochemical analysis Study protocol
Blood samples were taken from dRTA patients after an overnight fast at the time of bone biopsy. Serum Baseline biochemical parameters, including creatinine, electrolytes, calcium, phosphorus, serum intact electrolytes, calcium and phosphate were determined by using a Technicon Auto Analyzer. Serum iPTH was parathyroid hormone (iPTH), and 24-hour collection of urine for the determination of sodium, potassium, caldetermined by an immunoradiometric assay (ELSA-PTH; CIS BioInternational, GIF-sur-Yvette Cedex, France). cium, phosphate, and creatinine were obtained in all patients. Baseline bone mineral density of the spine and
The normal value for iPTH was 10 to 60 pg/mL. Twentyfour-hour urine collections for sodium, potassium, calfemur, radiography of the lumbar spine and pelvis, and transiliac crest bone biopsy were determined also in all cium, phosphate, and creatinine were obtained at the time of bone biopsy. Hypercalciuria on low calcium diets patients. Then, all of the patients were treated with 60 mEq/day of potassium citrate in two divided doses to (3.75 to 7.5 mmol/day of elemental calcium) was defined as a urinary calcium excretion Ͼ4.75 mmol/day in either keep the serum bicarbonate above 20 mmol/L throughout the study. Potassium citrate was provided in powder sex. Hypercalciuria on normal to high calcium diets (12-25 mmol/day of elemental calcium) was defined as a urinary form and in a 15-mEq package. For patients who initially failed to achieve the target serum bicarbonate level, the calcium excretion Ͼ6.0 mmol/day (female) or Ͼ6.5 mmol/ day (male); or Ͼ0.1 mmol/kg (either sex) [2, 12] . dosages of potassium citrate were increased in a stepwise as appropriate. There was a significant difference if the P value was less than 0.05.
Bone biopsy and bone histomorphometry
Transiliac crest bone samples were taken from the anterior superior iliac spine after tetracycline double la-RESULTS beling, using the same protocol reported previously [3] .
Most patients had short stature and low body mass index In brief, the bone specimens, 6 mm in diameter and 20 when compared to general Thai population (Table 1) . Alto 30 mm in length, were fixed for 24 hours in 70% most all of the patients (9 of 10) suffered from muscle ethanol, dehydrated, and embedded in methylmethacryweakness, and three patients developed urinary tract late. Undecalcified 6-micron thick sections were stained stones or nephrocalcinosis. Blood chemistries, serum with modified Masson-Goldner trichrome stain [13] , aurin iPTH levels, and 24-hour urinary excretion of sodium, tricarboxylic acid stain (Aluminon) [14] , Von-Kossa and potassium, calcium, and phosphate before and after pohematoxylin-eosin stain. If the specimen had a positive tassium citrate therapy are presented in Table 2 . At stain for aluminum, a further stain with Perls stain to baseline, all patients had hypokalemia, five patients had exclude cross-reaction with iron deposit was done. Unhypophosphatemia, but no patient had hypocalcemia. stained sections 15-microns thick were prepared for fluSerum iPTH levels were in the lower end of the normal orescent light microscopy. All sections, both pre-and range. The urinary excretion of calcium and phosphate post-potassium citrate therapy, were studied qualitawere relatively low. No patient had hypercalciuria at tively and quantitatively for static and dynamic paramebaseline. ters of bone formation and bone resorption by the same During potassium citrate therapy, all dRTA patients pathologist and technician, who had no knowledge of could maintain their serum bicarbonate above 20 mmol/L the patients' clinical presentations and treatments. Histothroughout the study with 60 to 90 mEq/day, or 1.65 Ϯ morphometric measurements were carried out with a 0.2 mEq/kg/day, of potassium citrate. Most patients resemiautomatic image analyzer (Osteomeasure; Osteoported a rapid improvement in their skeletal symptoms metric Inc, Atlanta, USA). At least 30 different fields after initiation of the treatment. There was a dramatic were analyzed for the same bone biopsy specimen. Histoimprovement in muscle strength in all dRTA patients morphometric parameters are expressed according to after two to three months of therapy. After treatment, serum potassium, bicarbonate, and phosphate levels were Parfitt et al's standardized nomenclature [15] . Reference significantly increased above the corresponding baseline normalized (Fig. 1) . Trabecular bone volume, osteoid thickness, osteoblastic and osteoclastic surfaces were values. There was no significant alteration in serum calmodestly elevated, but the differences were not significium level by the treatment. Urinary excretion of potascant. Differences in other histomorphometric paramesium and phosphate were significantly elevated, but there ters also were not significant. No positive staining for were no significant changes in the other urine constitaluminum was found in any of the bone specimens, either uents studied. Serum iPTH level was significantly elebefore or after treatment. There was no correlation bevated above the baseline value, but it was still within the tween the histomorphometric parameters and serum binormal limit.
carbonate, serum potassium, or serum phosphate at Bone mineral density at baseline and the end of the baseline, as well as no correlation between the alterations study period are shown in Table 3 . The basal BMD in histomorphometric parameters and the alterations in values of dRTA patients were significantly lower than the blood chemistries after treatment. those of normal controls in all studied areas (P Ͻ 0.05) except in the lumbar spine. After one year of alkaline therapy, there were significant elevations in BMD of DISCUSSION total femur and the trochanter of femur. The BMD in Potassium citrate therapy successfully corrected metaother studied areas also were elevated, but the differbolic acidosis by maintaining the serum bicarbonate level ences were not statistically significant.
above 20 mEq/L in our patients throughout the study. Bone histomorphometric data before and after treat-
The hypokalemia found initially in the majority of pament are presented in Table 4 . At baseline there was tients also was corrected. After treatment, there was a significant suppression in the bone formation rate (BFR), significant elevation in urinary excretion of potassium; and elevations in osteoid volume and osteoid surface comhowever, the increment in urinary potassium was lower pared to the corresponding parameters in normal conthan expected. Since most of the patients were farmers trols. There was no difference from normal control valwho spent most of their time in the field, excessive potasues in the other histomorphometric parameters. After sium loss in the sweat might be an additional route of potassium citrate therapy, BFR in dRTA patients was potassium loss from the body [16] . The mean value of potassium loss among normal farmers in the northeast significantly elevated above the baseline value and was patients. The bone formation rate was markedly suppressed in dRTA patients. There was a significant elevation in bone formation rate after one year of potassium citrate therapy in dRTA patients. The post-treatment values were within the lower limit of the normal range.
of Thailand was 11.5 mmol/day in summer and 7.4 mmol/ No patient was diagnosed with hypercalciuria at baseline and a reduction in urinary excretion of calcium was day in winter [17] . This amount of sweat potassium was about half or a third of urinary potassium excretion in not observed after treatment. This finding is in contrast to a few previous studies where hypercalciuria was inthe corresponding season. The discrepancy also might result from a positive potassium balance in the body, as duced by acute metabolic acidosis [20] [21] [22] . The increase in urinary calcium excretion after an acute acid load found in healthy men after taking a potassium bicarbonate supplement [18] . Acute metabolic acidosis is accomresults mainly from bone resorption [23] . However, an increase in bone resorption was not observed at baseline panied by a loss of sodium and potassium from bone surface [19] . Deposition of potassium together with carin our patients diagnosed with long-standing metabolic acidosis, which might differ in response from acute acidobonate in bone may take place after the correction of acidosis. There was no correlation between the dosage sis. Serum phosphate was significantly elevated by the treatment, which might result from a reduction in fracof potassium citrate and the baseline serum bicarbonate level. However, potassium citrate was increased in a steptional excretion of phosphate [24] , secondary to the effect of potassium loading on renal phosphate transport wise fashion in our study and there was no intention of finding a "threshold" dosage of potassium citrate.
[25, 26] and/or the collection of chronic metabolic acido-sis [27, 28] . Although serum iPTH also was elevated by bone histomorphometry and serum bicarbonate or sethe treatment, it was not associated with an elevation in rum phosphate, either the baseline values or after treaturinary excretion of phosphate. The collections of hypoment, was found in our study. kalemia and acidosis may overcome the effect of the eleMost in vitro or animal studies demonstrated that metvated serum iPTH on renal phosphate excretion in our abolic acidosis enhanced osteoclastic, but inhibited osteodRTA patients.
blastic activity [4, 6, 8] . This led to an uncertainty about The concentration of serum 1,25-(OH) 2 -vitamin D was whether concurrent metabolic derangement or chronic not determined in this study as it was unlikely for this metabolic acidosis contributed to the initial histologic group of patients to be vitamin D deficient, as they typifindings in our study. It is unknown whether the underlycally worked in sunny rice fields throughout the year ing cellular defect in dRTA is confined only to the renal [29] . Previous studies also demonstrated that metabolic tubular cell or extends to other cell lines. If a proton acidosis did not have a substantial impact on vitamin D pump defect affects both renal tubular cell and osteometabolism in humans [30] [31] [32] .
clast, metabolic acidosis may be unable to stimulate osteoMost of dRTA patients had a short stature based on clastic function during acidosis. After treatment, however, the normal Thai standard. Previous studies [1, 33] and the bone formation rate was markedly elevated and norour recent study in pediatric patients with dRTA [24] malized. The initial mineralization defect tended to imhave demonstrated growth retardation. Correction of prove, as indicated by the modest reduction in both osteacidosis markedly improved the growth rate. The effect oid surface and volume after treatment. There was also of metabolic acidosis on bone growth may be mediated, a tendency for the elevations in trabecular bone volume, at least in part, through the reduction in IGF-1 response osteoblastic and osteoclastic activities after treatment. to circulating growth hormone [34] as well as the resis-
The improvement in bone histology supports the causal tance of skeletal growth centers to growth hormone and role of acidosis in the alteration of bone histology found IGF-1 [35] . However, we found no correlation between initially in dRTA patients. Other factors, for example the height and the estimated age of onset of the disease the duration, age at onset, and the severity of the disorin our patients.
der, also might influence the response to the treatment. Bone mineral density in our patients also was markOur findings demonstrated suppression of parathyroid edly reduced in various areas. The femur was more afactivity in chronic metabolic acidosis. Although the basal fected than the lumbar spine. After alkaline therapy, there iPTH level was within the normal range, most of the were significant elevations in BMD of total femur and measurements were close to the lower limit. This finding trochanter of femur, suggesting the causal role of acidosis was consistent with the baseline low bone turnover in our in the reduction of bone loss in dRTA patients. It should dRTA patients and may explain the lack of hypercalciuria. be noted, however, that one year of alkaline therapy After one year of alkaline therapy, the serum iPTH level failed to completely normalize the BMD in our patients was significantly elevated in conjunction with a marked and a longer duration of treatment may be needed. In elevation in the bone formation rate and modest imaddition, the low or inadequate calcium intake in our provement in osteoblastic and osteoclastic activities. The patients might be a contributing factor, and may hinder elevation in iPTH was not a result of hypocalcemia or the improvement in BMD. Although dRTA has been increased urinary calcium excretion. The relatively low documented to be more severe or more frequently preserum iPTH may be a protective mechanism of the body sented in summer than in winter [11] , our patients were to prevent further reduction in bone mass when the body enrolled throughout the year and were treated soon after has suffered from chronic metabolic acidosis. An elevathe diagnosis was made. However, the timing of specition in ionized calcium induced by metabolic acidosis men collection should not have considerable effects on might initially suppress, and subsequently the significant bone histology as it normally takes a few months to deelevation in serum phosphate by the treatment might velop significant alterations in bone histology and BMD.
restore, parathyroid hormone secretion. The association As reported previously, suppression in both osteoblasbetween the elevated serum iPTH level and the correctic and osteoclastic activities were found in our dRTA tion of chronic acidosis in our study agrees with the patients [3] . The bone formation rate also was markedly finding in a previous human study, where a slight but suppressed. Our findings suggest that the low BMD significant reduction in serum iPTH level after a short found in dRTA patient resulted mainly from the reducperiod of increased acid load to the body was found [31] . tion in bone formation rather than the increased bone However, the finding is in conflict with a few previous resorption. Although there was some degree of mineralstudies in subjects with acute acidosis [32, 36, 37] . ization defect, suggested by the significant elevation in Regarding the pathogenesis, there is no adequate eviosteoid volume and osteoid surface, osteomalasia was dence to suggest whether dRTA in Thailand is an acquired not the predominant bone lesion [3] . Therefore, the hyor a congenital disorder. Defects in membrane transpophosphatemia found initially in our study was unlikely to be the cause of bone lesion. No relationship between porting proteins of the intercalated cell in renal collecting
